Gentry Leesa
CIK 2013097 · Chief Clinical Officer · last filed 2026-04-07
Gentry Leesa is a Chief Clinical Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for RNXT, was dated Apr 7, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNXT | Chief Clinical Officer | — | $0.86 | — | $0 | 4 | 2026-04-07 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-07 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2025-04-16 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | RNXT | Grant (A) | — | $0 | EDGAR |